T2
Payments companies reported to CMS as associated with T2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with T2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with T2
These are the largest totals companies reported as associated with T2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| J Dean Cole | Orlando, FL | Orthopaedic Trauma | $747,787.31 |
| Steven Haddad | Glenview, IL | Orthopaedic Surgery | $257,354.04 |
| Michael Maceroli | Atlanta, GA | Orthopaedic Trauma | $83,283.44 |
| Anthony Sorkin | Indianapolis, IN | Orthopaedic Trauma | $64,766.52 |
| Ryan Scott | Phoenix, AZ | Foot & Ankle Surgery | $60,492.30 |
| Brandon Yuan | Rochester, MN | Orthopaedic Surgery | $57,564.62 |
| Marcus Sciadini | Baltimore, MD | Orthopaedic Trauma | $53,946.06 |
| Timothy Achor | Houston, TX | Orthopaedic Trauma | $51,784.64 |
| William Davis | Charlotte, NC | Orthopaedic Surgery | $48,711.92 |
| David Forsh | New York, NY | Orthopaedic Surgery | $47,763.90 |
Prescribed T2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.